VCM
CELU icon

Vivaldi Capital Management’s Celularity CELU Stock Holding History

Vivaldi Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,321
Closed -$145K – 364
2020
Q4 		$145K Sell
1,321
-1,336
-50% -$142K 0.03% 277
2020
Q3 		$279K Sell
2,657
-304
-10% -$31.5K 0.06% 201
2020
Q2 		$302K Buy
2,961
+961
+48% +$95.4K 0.06% 194
2020
Q1 		$196K Buy
+2,000
New +$198K 0.04% 184

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Vivaldi Capital Management's CELU Position: Q1 2021 in Review

Vivaldi Capital Management sold out of Celularity (CELU) in Q1 2021, closing a stake of 1,321 shares — an estimated $145K sold.

Vivaldi Capital Management first reported a position in CELU in Q1 2020 and held it in 4 quarters. The position peaked at $302K in Q2 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • Vivaldi Capital Management reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • Vivaldi Capital Management sold 1,321 Celularity shares in Q1 2021, an estimated $145K.
  • Vivaldi Capital Management first reported a position in Celularity in Q1 2020 and held it in 4 quarters.
  • Vivaldi Capital Management's Celularity position peaked at $302K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Vivaldi Capital Management's 13F filing for Q1 2021, filed 17 May 2021.